| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Arrowhead Pharmaceuticals, Inc. (ARWR) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. ARWR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.79M | $311.00M | - | |
| COO | 473.3K | $38.81M | - | |
| Other | 227.0K | $18.61M | - | |
| CFO | 162.9K | $13.36M | - | |
| Dir | 123.1K | $10.09M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 15, 2021 | Given Douglas B66 | Director | Sell | 3,000 | $83.28 | $249,840.00 | -19.4% | |
| Jan 14, 2021 | Hamilton James C72 | Senior Vice President | Sell | 10,000 | $81.29 | $812,941.90 | -3.8% | |
| Jan 12, 2021 | Myszkowski Kenneth Allen68 | Chief Financial Officer | Sell | 13,038 | $81.02 | $1,056,309.94 | -1.4% | |
| Jan 7, 2021 | Hassard James61 | Chief Commercial Officer | Sell | 15,625 | $75.00 | $1,171,875.00 | -12.5% | |
| Jan 6, 2021 | Myszkowski Kenneth Allen68 | Chief Financial Officer | Sell | 30,625 | $72.44 | $2,218,477.01 | -2.1% | |
| Jan 6, 2021 | O'Brien Patrick76 | General Counsel | Sell | 25,000 | $72.41 | $1,810,345.62 | -2.7% | |
| Jan 6, 2021 | Hamilton James C72 | Senior Vice President | Sell | 38,750 | $72.51 | $2,809,578.46 | -3.4% | |
| Jan 4, 2021 | Perry Michael S55 | Director | Sell | 4,000 | $76.09 | $304,360.00 | -4.3% | |
| Jan 4, 2021 | Given Douglas B66 | Director | Sell | 4,000 | $76.08 | $304,320.00 | -3.2% | |
| Jan 4, 2021 | Waddill William D.50 | Director | Sell | 3,750 | $76.08 | $285,300.00 | -11.0% |